✦ LIBER ✦

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

✍ Scribed by Saltz, L. B.

Book ID: 126231419
Publisher: American Society of Clinical Oncology
Year: 2004
Tongue: English
Weight: 107 KB
Volume: 22
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2004.10.182

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1086 Cetuximab in a randomized phase II

1086 Cetuximab in a randomized phase II trial as a single agent or in combination with irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing, irinotecan-refractory metastatic colorectal cancer (CRC)

✍ Van Cutsem, E.; Gascón Vilaplana, P.; Seitz, J.F.; Van Laethem, J.L.; Grossi, F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Trichomegaly of the Eyelashes After Colo

Trichomegaly of the Eyelashes After Colorectal Cancer Treatment With the Epidermal Growth Factor Receptor Inhibitor Cetuximab

✍ Richard Bambury; J.A. McCaffrey 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 174 KB

Epidermal growth factor receptor gene co

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab

✍ Carla Campanella; Marcella Mottolese; Anna Cianciulli; Angela Torsello; Roberta 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 456 KB

Biweekly cetuximab plus irinotecan as se

Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory andKRASwild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status

✍ Myoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, Sun Young Kim, Ji Yeon Baek, Min-H 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 166 KB

Phase II trial of cetuximab and carbopla

Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study

✍ Angeles Alvarez Secord; John A. Blessing; Deborah K. Armstrong; William H. Rodge 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Dual Targeting of the Epidermal Growth F

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

✍ Weickhardt, A. J.; Price, T. J.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 240 KB